Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Freenome

Request full access

A health technology company developing accurate, accessible and non-invasive disease screening products

San Francisco, United StatesFounded 2014Biotech & Life Sciences

At a glance

Status
Listed
Listing
Public via SPAC 2026

Freenome in the San Francisco ecosystem

Live from Dealroom

The Freenome office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

48 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed5 investors entered at this stage

Series A9 investors entered at this stage

Series B and later34 investors entered at this stage

  • Kaiser Permanente Ventures
  • EcoR1 Capital
  • T. Rowe Price
  • Quest Diagnostics
  • Logos Capital
  • Squarepoint Capital
  • Farallon Capital Management
  • Kaiser Permanente
  • Roche
  • ARK Invest
  • Roche Venture Fund
  • RA Capital Management
  • BrightEdge
  • Fidelity Investments
  • HBM Healthcare Investments
  • Rock Springs Capital
  • Pura Vida Investments
  • Eventide Asset Management
  • Sands Capital Management
  • Cormorant Capital
  • The Colon Cancer Alliance
  • Novartis
  • Cormorant Asset Management
  • ArrowMark Partners
  • Perceptive Advisors
  • Artis Ventures
  • Ridgeback Capital
  • Intermountain Ventures
  • Bain Capital Life Sciences
  • Suvretta Capital Management
  • Catalio Capital Management
  • Janus Henderson Investors
  • Byers Capital
  • Soleus Capital

Ownership

Share of equity by holder

Share of equity by holder, from Dealroom's shareholder data. Stakes as last recorded by Dealroom (2026).

32.5% Roche

See the full cap table on Dealroom →

Employees mapped 403 incl. 14 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 15 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 10 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$7M

21 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Freenome on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.